breast neoplasms/phosphatase

FIELD OF THE INVENTION The present invention relates to methods for treating cancer. BACKGROUND OF THE INVENTION Each year 1.1 million new cases of breast cancer occur among women worldwide and 400,000 women will die from this disease (www.uicc.org, www.who.int). Although progress has been made in

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to biomolecules that mediate biological signal transduction in cells, which signals are communicated by phosphorylation and dephosphorylation of cellular proteins for processes such as cellular

BACKGROUND OF THE INVENTION Intercellular protein tyrosine phosphorylation is regulated by extracellular stimuli, such as cytokines, to control cell growth, differentiation and functional activities. This signaling mechanism depends on the interplay of protein tyrosine kinases, which initiate

BACKGROUND OF THE INVENTION Intercellular protein tyrosine phosphorylation is regulated by extracellular stimuli, such as cytokines, to control cell growth, differentiation and functional activities. This signaling mechanism depends on the interplay of protein tyrosine kinases, which initiate

This application incorporates by reference the contents of a 200 kb text file created on Apr. 19, 2013 and named "13819933sequencelisting.txt," which is the sequence listing for this application. Each reference cited in this disclosure is incorporated herein by reference in its entirety. BRIEF

TECHNICAL FIELD The invention relates to compositions, kits and methods for diagnosis, research and prognosis of cancer and other conditions, by analyzing the entire kinome of cells and tissues. BACKGROUND Most cellular signaling pathways are regulated by post-translational modification of proteins,

FIELD OF THE INVENTION The invention relates generally to compounds for the treatment of medical conditions involving hormones. More specifically, the invention relates to compounds, their preparation and their use in the treatment of hormone-dependent diseases including hormone-dependent cancers. A